Market Research Reports, Inc. has announced the addition of “Ovarian Cancer - Pipeline Review, H1 2017” research report to their offering. See more at - http://mrr.cm/UKk

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: June 30, 2017
 Number of Pages: 2027
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 2,500
Price For Site User License: USD 5,000
Price For Global User License: USD 7,500
Delivery Time: Within 24 Hours (During Working
Days)

3. www.MarketResearchReports.com
About the Report
Ovarian Cancer - Pipeline Review, H1 2017,
provides an overview of the Ovarian Cancer
(Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may
occur in different parts of the ovary. The majority
of ovarian cancers arise from the epithelium (outer
lining) of the ovary.

4. www.MarketResearchReports.com
Report Highlights;
This report provides comprehensive information on the
therapeutics under development for Ovarian Cancer
(Oncology), complete with analysis by stage of
development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological
action of the therapeutics, its complete research and
development history and latest news and press
releases.
The Ovarian Cancer (Oncology) pipeline guide also
reviews of key players involved in therapeutic
development for Ovarian Cancer and features dormant
and discontinued projects.

5. www.MarketResearchReports.com
Report Highlights; Continues…
The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules
developed by Companies in Pre-Registration, Filing
rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA
Filed, Preclinical, Discovery and Unknown stages are 4,
2, 15, 135, 128, 7, 208, 21 and 5 respectively.
Ovarian Cancer (Oncology) pipeline guide helps in
identifying and tracking emerging players in the market
and their portfolios, enhances decision making
capabilities and helps to create effective counter
strategies to gain competitive advantage.
The guide is built using data and information sourced
from Publisher’s proprietary databases,
company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and
featured press releases from company/university sites
and industry-specific third party sources.

6. www.MarketResearchReports.com
Scope:
The pipeline guide provides a snapshot of the global
therapeutic landscape of Ovarian Cancer (Oncology).
The pipeline guide reviews pipeline therapeutics for
Ovarian Cancer (Oncology) by companies and
universities/research institutes based on information
derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on
several stages of development ranging from pre-
registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles
for the pipeline products which comprise, product
description, descriptive licensing and collaboration
details, R&D brief, MoA & other developmental
activities.
The pipeline guide encapsulates all the dormant and
discontinued pipeline projects.

7. www.MarketResearchReports.com
Scope: Continues…
The pipeline guide reviews key companies involved in
Ovarian Cancer (Oncology) therapeutics and enlists all
their major and minor projects.
The pipeline guide evaluates Ovarian Cancer
(Oncology) therapeutics based on mechanism of action
(MoA), drug target, route of administration (RoA) and
molecule type.
The pipeline guide reviews latest news related to
pipeline therapeutics for Ovarian Cancer (Oncology)

8. www.MarketResearchReports.com
Reasons to buy:
Procure strategically important competitor information,
analysis, and insights to formulate effective R&D
strategies.
Recognize emerging players with potentially strong
product portfolio and create effective counter-strategies
to gain competitive advantage.
Find and recognize significant and varied types of
therapeutics under development for Ovarian Cancer
(Oncology).
Classify potential new clients or partners in the target
demographic.
Develop tactical initiatives by understanding the focus
areas of leading companies.
Plan mergers and acquisitions meritoriously by
identifying key players and it’s most promising pipeline
therapeutics.

9. www.MarketResearchReports.com
Reasons to buy: Continues…
Formulate corrective measures for pipeline projects by
understanding Ovarian Cancer (Oncology) pipeline
depth and focus of Indication therapeutics.
Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the
most attractive projects to enhance and expand
business potential and scope.
Adjust the therapeutic portfolio by recognizing
discontinued projects and understand from the know-
how what drove them from pipeline.

10. www.MarketResearchReports.com
Report Coverage:
1. Introduction
2. Ovarian Cancer - Overview
3. Ovarian Cancer - Therapeutics Development
4. Ovarian Cancer - Therapeutics Assessment
5. Ovarian Cancer - Companies Involved in
Therapeutics Development
6. Ovarian Cancer - Drug Profiles
7. Ovarian Cancer - Dormant Projects
8. Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

11. www.MarketResearchReports.com
Company Coverage: (Partial List)
1. 3-V Biosciences Inc
2. 4SC AG
3. AB Science SA
4. AbbVie Inc
5. AbGenomics International Inc
6. Adaptimmune Therapeutics Plc
7. Boston Biomedical Inc
8. Bristol-Myers Squibb Company
9. Calithera Biosciences Inc
10. CASI Pharmaceuticals Inc
11. DelMar Pharmaceuticals Inc
12. Dr. Reddy's Laboratories Ltd
13. Ecrins Therapeutics SAS
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

12. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

13. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/UKk
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)